Skip to main content
Fig. 6 | Journal of Nanobiotechnology

Fig. 6

From: Secured delivery of basic fibroblast growth factor using human serum albumin-based protein nanoparticles for enhanced wound healing and regeneration

Fig. 6

Low dose wound healing activity and histological evaluation of wound sections in vivo. (A) Representative photographs of the rat skin wound healing treated with HSA NPs and HSA-bFGF NPs, compared to NT at day 0, 3, 6, 9, 12, and 14. Dosage of loaded bFGF in HSA-bFGF NP was 3 µg. The boundary between hairy area and the non-hairy area of skin was marked (dashed line, red). Scale bars, 5 mm. (B) Quantitatively analyzed wound size reduction profile. n = 3 to 5. (C) Representative H&E staining images of the wound skin upon different treatments. Panniculus gap was presented as dashed lines and arrows (black). Thickness of regenerated skin treated with HSA-bFGF NPs was thicker compared to other groups. Scale bars, 1 mm. (D) Magnified H&E staining images of each skin designated as a solid box (blue) in (C). Though hyperproliferative epidermis layer shows not completely recover the wound, the wound was shown to be in the process of recovering. Scale bars, 100 μm

Back to article page